IPW vs NBIX · rev $66.1M vs P/E 45, rev $2.36B
iPower Inc (IPW) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
iPower Inc (IPW) is a internet retail company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported IPW revenue for 2025-06-30 was $66.1M. Revenue was down 23.2% from 2024-06-30 to 2025-06-30. IPW currently screens at market cap $20.1M.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
IPW currently screens at market cap $20.1M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the IPW and NBIX stock pages for the full models.
Not investment advice.